POSSIBLE INVOLVEMENT OF VASOACTIVE INTESTINAL POLYPEPTIDE IN THE CENTRAL STIMULATING ACTION OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE ON PROLACTIN SECRETION IN THE RAT
K. Yamauchi et al., POSSIBLE INVOLVEMENT OF VASOACTIVE INTESTINAL POLYPEPTIDE IN THE CENTRAL STIMULATING ACTION OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE ON PROLACTIN SECRETION IN THE RAT, Neuroscience letters, 189(2), 1995, pp. 131-134
Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) o
n prolactin (PRL) secretion was studied in Wistar strain male rats in
vivo. Intravenous injection of PACAP-38 and PACAP-27 resulted in a dos
e-related increase in plasma PRL levels both in conscious rats and in
urethane-anesthetized rats. In anesthetized animals, i.c.v, injection
of PACAP-38 and PACAP-27 also elicited a dose-related increase in plas
ma PRL. The PRL secretion induced by i.c.v, injection of PACAP-38 was
attenuated by pretreatment with rabbit antiserum to vasoactive intesti
nal polypeptide (VIP). These findings suggest that PACAPs stimulate PR
L secretion in the rat by acting not only directly on the pituitary bu
t also indirectly through the central nervous system, at least partly,
via hypothalamic VIP.